Drug Updates

Dr. Moopen’s Family Fortifies Investment in Aster DM Healthcare with 4% Stake Increase

Posted on Author Comment(0)

The Moopen family, promoters of Aster DM Healthcare, has raised their stake in the India-listed company by 4%, from 37.88% to 41.88%. This expansion was achieved by acquiring additional shares worth Rs 460 Crore (Dh. 207 million) from a prominent private equity investor.

Dr. Azad Moopen, the Founder Chairman and Managing Director, emphasized the family’s commitment to the business, its patients, and employees. Aster DM Healthcare, with a revenue of Rs. 10,253 crore in FY 2021-22, is experiencing significant growth due to restructuring efforts in India and GCC.

The company has numerous upcoming projects in India and is expanding its presence in the GCC with new hospitals and pharmacies. The myAster App, already boasting 352,000+ downloads, will connect all facilities, providing an omnichannel healthcare experience.

Author

https://swasthsamachar.com

Related Articles
Drug Updates

Biosensors Market to Grow USD 21280 million by 2028 with a CAGR of 8.5% | Valuates Reports

Posted on Author

Biosensors Market is Segmented by Type (Non-wearable Biosensor, Wearable Biosensor), By Application (Medical Science, Environmental Monitoring, Food, Agriculture, Others): Opportunity Analysis and Industry Forecast, 2022–2028. It is published in Valuates Reports under the Pharmaceuticals & Biotech Category.Biosensors market size is estimated to be worth USD 13040 million in 2022 and is forecast to be a […]
Drug Updates

LOTTE BIOLOGICS Holds ‘ESG Declaration Ceremony’

Posted on Author

LOTTE BIOLOGICS is embarking on full-fledged ESG (Environmental, Social, and Governance) management. On August 30, LOTTE BIOLOGICS, under the leadership of CEO Richard Lee, held its ‘ESG Declaration Ceremony’ at the Executive Briefing Center (EBC) on the 113th floor of LOTTE World Tower. The ceremony included an address by the CEO and Sung-wook Cho, Head […]
Drug Updates

CLENSTA expands partnership with CIPLA to improve access to personal hygiene

Posted on Author

Clensta International, an IIT Delhi partnered healthcare start-up revolutionizing the personal hygiene space, recently announced extension of their marketing and distribution partnership with Cipla, one of the leading global pharmaceutical company in India for its waterless technology products. This deal will redefine the hygiene and cleanliness for patients in hospital setups, primarily focusing on ICUs […]

Leave a Reply

Your email address will not be published. Required fields are marked *